Rep. Tim Moore Purchases Shares of Centene Corporation (NYSE:CNC)

Key Points

• Representative Tim Moore purchased between $15,001 and $50,000 in shares of Centene Corporation (NYSE:CNC) on August 7th.
• Centene reported a loss of ($0.16) EPS for the last quarter, falling short of expectations, despite a 22.4% increase in revenue year-over-year.
• Several analysts have downgraded Centene's stock ratings and significantly reduced their price targets, reflecting changing market sentiment.

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation NYSE: CNC. In a filing disclosed on September 03rd, the Representative disclosed that they had bought between $15,001 and $50,000 in Centene stock on August 7th.

Representative Tim Moore also recently made the following trade(s):

• Sold $100,001 - $250,000 in shares of Centene NYSE: CNC on 8/18/2025.
• Sold $50,001 - $100,000 in shares of UnitedHealth Group NYSE: UNH on 8/15/2025.
• Sold $100,001 - $250,000 in shares of Intel NASDAQ: INTC on 8/13/2025.
• Sold $50,001 - $100,000 in shares of Hyster-Yale NYSE: HY on 8/13/2025.
• Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/12/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 8/11/2025.
• Purchased $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 8/8/2025.
• Purchased $1,001 - $15,000 in shares of Centene NYSE: CNC on 8/8/2025.
• Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 8/8/2025.
• Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/7/2025.

Centene Stock Performance

CNC opened at $28.62 on Friday. Centene Corporation has a 1-year low of $25.08 and a 1-year high of $77.29. The company has a 50 day simple moving average of $30.30 and a two-hundred day simple moving average of $49.01. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. The firm has a market cap of $14.06 billion, a P/E ratio of 7.08, a PEG ratio of 1.22 and a beta of 0.44.

Centene (NYSE:CNC - Get Free Report) last released its earnings results on Friday, July 25th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of $0.23 by ($0.39). Centene had a return on equity of 9.57% and a net margin of 1.15%.The company had revenue of $48.74 billion during the quarter, compared to analysts' expectations of $44.71 billion. During the same period last year, the firm posted $2.42 EPS. Centene's quarterly revenue was up 22.4% compared to the same quarter last year. Centene has set its FY 2025 guidance at 1.750-1.750 EPS. Equities analysts forecast that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Insider Buying and Selling at Centene

In other Centene news, Director Theodore R. Samuels II purchased 9,000 shares of the stock in a transaction on Monday, July 28th. The stock was bought at an average price of $27.62 per share, for a total transaction of $248,580.00. Following the acquisition, the director directly owned 32,000 shares of the company's stock, valued at $883,840. This represents a 39.13% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, CEO Sarah London purchased 19,230 shares of the stock in a transaction on Friday, August 8th. The stock was acquired at an average price of $25.50 per share, with a total value of $490,365.00. Following the acquisition, the chief executive officer directly owned 845,275 shares in the company, valued at $21,554,512.50. This trade represents a 2.33% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.36% of the stock is owned by company insiders.

Institutional Trading of Centene

A number of large investors have recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its stake in shares of Centene by 8.8% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 2,092 shares of the company's stock worth $127,000 after buying an additional 169 shares during the period. Quadcap Wealth Management LLC increased its stake in Centene by 3.2% in the first quarter. Quadcap Wealth Management LLC now owns 5,617 shares of the company's stock valued at $341,000 after purchasing an additional 172 shares during the last quarter. Poinciana Advisors Group LLC grew its position in shares of Centene by 2.8% during the first quarter. Poinciana Advisors Group LLC now owns 7,221 shares of the company's stock worth $438,000 after acquiring an additional 195 shares during the last quarter. Carnegie Investment Counsel grew its position in shares of Centene by 6.0% during the first quarter. Carnegie Investment Counsel now owns 3,811 shares of the company's stock worth $234,000 after acquiring an additional 215 shares during the last quarter. Finally, Allworth Financial LP lifted its holdings in shares of Centene by 6.1% during the first quarter. Allworth Financial LP now owns 4,387 shares of the company's stock worth $270,000 after purchasing an additional 254 shares during the period. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CNC. Wall Street Zen downgraded shares of Centene from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Robert W. Baird lowered their price target on shares of Centene from $68.00 to $28.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Bank of America cut shares of Centene from a "neutral" rating to an "underperform" rating and lowered their target price for the stock from $52.00 to $30.00 in a research note on Wednesday, July 16th. Oppenheimer reduced their price target on shares of Centene from $51.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, July 28th. Finally, Wells Fargo & Company lowered shares of Centene from an "overweight" rating to an "equal weight" rating and cut their target price for the company from $72.00 to $30.00 in a report on Wednesday, July 23rd. Three investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $41.40.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.